別ウィンドウで開きます
English別ウィンドウで開きます Connect with MDV
Home > Service > MDV analyzer for Clinical Insight

MDV analyzer for Clinical Insight

MDV analyzer for Clinical Insight

Web Tool Service

MDV analyzer for Clinical Insight

Support Tool for Publication and Safety Reviews
MDV analyzer for Clinical Insight

This tool can be used to assess feasibility during research reviews within the field of Medical Affairs.
It is also valuable in the field of Safety by supporting the planning of post-marketing database studies,
identifying safety review issues, developing pharmacovigilance plans, and implementing risk minimization strategies.

    Setting image tree image
Clinical Insight
Free Trial
Clinical Insight
User Login
Contact us

EBM Medical Database

⁠We collect anonymized data derived from medical institutions, including DPC data, claims data, and laboratory test results. This data is primarily used by pharmaceutical companies and medical device manufacturers for marketing research, database studies, and safety assessments.

construction of the Medical Database for MDV analyzer for Clinical Insight

Feature Overview

This tool is tailored to the field of Medical Affairs, supporting feasibility studies and protocol validation through database research.
It also aids in safety assessments by monitoring event incidence and testing rates.

Main Features of MDV analyzer for Clinical Insight

  • ⁠⁠Event distribution histogram
  • ⁠Ranking of drugs, diseases, and medical procedures
  • Patient demographic analysis
  • Treatment duration
  • Patient Journey

⁠Ranking of drugs, diseases, and medical procedures

Capturing the actual conditions of diseases, drug usage, and clinical procedures at each point in the timeline allows for the early detection of potential risks.

⁠Ranking of drugs, diseases, and medical procedures image1
⁠Ranking of drugs, diseases, and medical procedures image2

Event distribution histogram

⁠Time-to-event histograms can be reviewed. Furthermore, since it is possible to set customizable parameters such as treatment continuation rates and pre-event exclusion periods, this feature is well-suited for hypothesis testing, safety monitoring, and protocol validation.

Event distribution histogram image1
Event distribution histogram image2

⁠Patient demographic analysis

⁠You can obtain background information on the study population.
This includes not only basic demographic data such as gender and age, but also health status based on comorbidities and laboratory test values.

⁠Patient demographic analysis image1
⁠Patient demographic analysis image2

Treatment duration

⁠⁠It is possible to analyze treatment persistence as an indicator of therapeutic effectiveness.

Treatment duration image1
Treatment duration image2

Patient Journey

⁠It is possible to gain insights into the current treatment landscape, including therapeutic potential and positioning, in the context of new drug launches or the addition of new indications.
Furthermore, the database allows for the identification of patient groups that align with your Medical Affairs strategy.

Patient Journey
Clinical Insight
Free Trial
Clinical Insight
User Login
Contact us

Main Steps to Get Started

Demo (feature overview)

Our representative will provide an introduction to the types of analyses that can be performed using each web tool.

下矢印

Consultation

The most suitable web tool will be proposed.

下矢印

Contract

Once the tool has been decided, we will provide a draft contract accordingly

下矢印

Delivery

We will set up the necessary accounts and share the login IDs and passwords prior to the start of service.

FAQs

Before use

Currently, the web tool is not available for trial purpose. Our representative can provide an introduction to the web tool based on your specific requirements. Please feel free to contact us.
Our representative can provide an introduction on how the web tool operates in advance. Please feel free to contact us.
We have brochures for our web tool services. Please contact us if you are interested.

About the specifications

Marketing: Prescription trends, market analysis, etc.
Academia and pharmacovigilance: Exploring potential research, regulatory submission, etc.
R&D: Field research, assessing status of drugs with similar effects to those under development, etc.
Maintenance is performed once a month, and the latest data becomes available after the maintenance.
It is possible. However, prior to publication, we require a third-party disclosure agreement（TPA) with our company and a review of the materials to be published.
We receive many disclosure requests every year, and the results are used not only for regulatory submissions but also during meetings with physicians.
The data analysis uses actual values, and some features have been implemented to allow for extrapolation, enabling you to view national-level data.
Within a single organization, there is no additional cost for using multiple accounts.
Yes, it is possible through a VPN connection or similar means.
Some of the web tools are available in English, please feel free to contact our representative for more information.

About the Hospital data

Currently, we have a coverage rate of approximately 30% of the 1,786 DPC-designated hospitals nationwide (as of December 31, 2024).
We collect insurance claim data for both inpatient and outpatient visits.
They are mainly advanced treatment hospitals, so they tend to have a higher number of patients with more severe conditions compared to clinics. However, there is also a significant number of patients in primary care areas, such as those with lifestyle-related diseases, and we receive many requests for analysis.
Our data covers DPC hospitals nationwide, and the age and gender distribution of patients is similar to the survey published by the Ministry of Health, Labour and Welfare regarding the patient distribution in medical institutions across Japan. Therefore, it is considered to be representative.
Since it is the largest database in Japan with over 50 million patients, the data has been utilized in research in different fields, including intractable and rare diseases.
Update is performed at the end of every month, and the data two months prior to the update will be the latest data. (For example, the data of January 2021 will be available after the update performed at the end of March 2021)
Given the large scale of the database, we are confident that we can secure a robust number of cases for research in any disease area.
The web tool does not currently include data fields for assessing disease severity. However, through a separate service, it is possible to obtain data fields that allow for the assessment of severity in certain disease areas.
There is a function in MDV analyzer that allows one to perform extrapolation to obtain results at the national level.
Each DPC hospital assigns a unique hospital-specific ID to each patient. Therefore, tracking is possible for both inpatient and outpatient data within the same DPC hospital. However, tracking after transfer to another hospital is not possible.
Unfortunately, our database only includes medical information that is eligible for insurance reimbursement, as it is based on claim data.
Clinical Insight
Free Trial
Clinical Insight
User Login
Contact us

page top

© Medical Data Vision Co., Ltd. All Rights Reserved.